A (sort-of) workaround would be to count ambiguous reads for both genes:
-
This seems to be an interesting edge-case. So, TUBB3 and MC1R can form fusion transcripts and fusion proteins. So ENSG00000198211 isn't a mistake and htseq-count isn't doing anything incorrect. However, cases like this are really annoying for read counting. The simplest solution would be to just remove the entries for ENSG00000198211 in your GTF file. The actual correct solution would require a different annotation format that can account for non-novel fusion events of genes that are properly annotated and analyzed as separate in many cases. Such a format will probably get created someday, but I imagine it'll take a while.Leave a comment:
-
Dear dpryan,Originally posted by dpryan View Post
Thank you for your reply. I have checked the results, It showed htseq classified most of the reads of this region into "ambiguous" condition, and they belong to ENSG00000198211.8 + ENSG00000258947.3. However, i checked these two genes. Both of them are TUBB3 gene. One is Chromosome 16: 89,921,392-89,938,761 and the other is Chromosome 16: 89,919,165-89,936,092. I understand this problem is not caused by the Htseq software. However, if we discard these reads, it will have a huge impact on expression of this TUBB3 gene (Htseq count 7, but there are dozens).
Do you have any ideas about this?
ThanksLeave a comment:
-
Just use the -o option to track how the reads are being categorized. Then you can simply look and see why they're not being counted.Leave a comment:
-
Htseq question
Hi, all,
i just got a result from ht-seq. It showed that my interesting gene has 7 counts in the alignment. However, from the view of IGV, i could easily identify much more counts than 7 on this gene. My alignment is from STAR, and i used more stringent parameters to control the multiple alignment, which means there should not be any multiple aligned reads in the output. I am really confused about this.
Any suggestion?
-
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...12-16-2024, 07:57 AM -
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...12-02-2024, 01:49 PM
Leave a comment: